Parkinson's Disease News and Research

Latest Parkinson's Disease News and Research

COE on Brain Aging at NYU Langone establishes Lewy Body Disease Center

The Center of Excellence (COE) on Brain Aging at NYU Langone Medical Center has established a specialty center for the diagnosis and treatment of Lewy Body Disease, a multi-system disease involving disturbances of cognition, behavior, sleep and autonomic function. Lewy Body Disease, or LBD, affects an estimated 1.3 million individuals in the United States and is widely misdiagnosed because LBD symptoms closely resemble those of other more commonly known diseases such as Alzheimer's and Parkinson's disease.

30 Sep 2010

NINDS establishes new sites as part of Morris K. Udall Centers of Excellence in Parkinson's Disease Research

The National Institute of Neurological Disorders and Stroke (NINDS), a component of the National Institutes of Health, has established two new sites as part of the Morris K. Udall Centers of Excellence in Parkinson's Disease Research. The NINDS grants will provide a five-year investment totaling more than $16 million for Emory University in Atlanta and the Feinstein Institute for Medical Research in Manhasset, N.Y.

29 Sep 2010

Synosia's SYN-118 HPPD inhibitor beneficial for Parkinson's patients: Study

Synosia Therapeutics today announced the first clinical study results showing that SYN-118 provides clinically meaningful benefits to Parkinson's patients, has a good safety profile and is well tolerated. Results from an open-label, proof-of-mechanism study of SYN-118 (CL02) were presented at the World Parkinson Congress in Glasgow, Scotland.

29 Sep 2010

Brain cells outside damaged area in stroke patients take on new roles

The world's largest study using neuroimaging of stroke patients struggling to regain ability to communicate finds that brain cells outside the damaged area can take on new roles.

29 Sep 2010

XenoPort to present XP21279 clinical trial data at World Parkinson Congress meeting

XenoPort, Inc. announced today that new data from its first clinical trial of XP21279, a Transported Prodrug of L-Dopa, in Parkinson's disease patients will be presented at the upcoming World Parkinson Congress meeting in Glasgow, Scotland.

29 Sep 2010

Study indicates majority of children suffering from chronic headache may outgrow the condition

Most children who suffer from chronic daily headache may outgrow the disabling condition, according to research published in the July 15, 2009, online issue of NeurologyÂ®, the medical journal of the American Academy of Neurology.

28 Sep 2010

Higher education levels increases need for symptomatic control of Parkinson's disease

Individuals who have higher levels of education and who are more impaired by Parkinson's disease appear to require treatment for their symptoms earlier than do other patients, according to a report posted online today that will appear in the September print issue of Archives of Neurology, one of the JAMA/Archives journals.

28 Sep 2010

Michael J. Fox Foundation launches PPMI clinical study to identify Parkinson's disease biomarkers

The Michael J. Fox Foundation has launched the Parkinson's Progression Markers Initiative (PPMI), the first ever large scale clinical study exclusively focused on identifying and validating Parkinson's disease biomarkers.

28 Sep 2010

People with Parkinson's disease have high levels of beta-HCH pesticide

People with Parkinson's disease have significantly higher blood levels of a particular pesticide than healthy people or those with Alzheimer's disease, researchers at UT Southwestern Medical Center have found.

27 Sep 2010

Alzheimer's treatments may prove effective if started in middle-aged people: Study

Memory lapses that occur with normal aging are a source of worry for many who fear Alzheimer's disease. Now a new Mayo Clinic-led study published in the July 16 issue of the New England Journal of Medicine suggests that the carriers of a common genetic risk factor for Alzheimer's disease begin to have memory declines in their mid-50s, far earlier than previously thought.

27 Sep 2010

Individuals with growing amount of white matter hyperintensities are more likely to develop dementia

Elderly people with no memory or thinking problems are more likely to later develop thinking problems if they have a growing amount of "brain rust," or small areas of brain damage, according to a study published in the July 14, 2009, print issue of NeurologyÂ, the medical journal of the American Academy of Neurology.

27 Sep 2010

FDA designates AMT-080 gene therapy for Duchenne muscular dystrophy

Amsterdam Molecular Therapeutics (AMT) Holding N.V. a leader in the field of human gene therapy, announced today that the U.S. Food and Drug Administration (FDA) has designated AMT-080, a gene therapy for Duchenne muscular dystrophy (DMD) as an orphan drug.

24 Sep 2010

Gait disruption increases risk of falls in Parkinson's patients: Study

We've all heard the saying about people who can't walk and chew gum at the same time, but it turns out that walking and talking is difficult enough, especially for people with Parkinson's disease who are at increased risk for falls with injury.

23 Sep 2010

New study signals hope for treatment of rare neurodegenerative disease

A new study led by St. Jude Children's Research Hospital scientists signals hope for treatment of a neurodegenerative disease and a new model for understanding the mechanism at work in other more common neurodegenerative disorders.

23 Sep 2010

ARRA's legacies may solve challenges related to health, energy and environment

The presidents of six leading research universities and two higher-education associations joined Vice President Joe Biden and White House science advisor Dr. John Holdren this morning to discuss the scientific research and related activities that have been made possible by the American Recovery and Reinvestment Act (ARRA).

22 Sep 2010

Researchers explain how nerve cells transmit electrical signals

Billions of brain cells are communicating at any given moment. Like an organic supercomputer they keep everything going, from breathing to solving riddles, and "programming errors" can lead to serious conditions such as schizophrenia, Parkinson's disease and attention-deficit hyperactivity disorder.

22 Sep 2010

Deep brain stimulation improves OCD symptoms, promotes smoking cessation and weight loss

Electrical stimulation of the brain in a patient with severe obsessive-compulsive disorder (OCD) led to some unanticipated benefits—"effortless" smoking cessation and weight loss, according to a case report in the September issue of Neurosurgery, official journal of the Congress of Neurological Surgeons.

22 Sep 2010

ASM awards UTHealth student 3-year, $33,000 fellowship for study of molecular details of protein folding in cells

Jennifer Abrams, a graduate student at The University of Texas Health Science Center at Houston (UTHealth), has been awarded a three-year, $33,000 fellowship from the American Society for Microbiology (ASM) to support her innovative research into the molecular causes of protein misfolding diseases like Alzheimer's, Lou Gehrig's and Parkinson's.

21 Sep 2010

Voice disorders are not benign nuisances that go away

Two-thirds of Americans with voice problems don't seek medical care either because they don't know treatment is available or because they think the problem will just go away, according to a new study conducted at the Duke Voice Care Center.

21 Sep 2010

Alpha-synuclein protein in Parkinson's disease inhibits autophagy: Research

A protein linked to Parkinson's disease may cause neurodegeneration by inhibiting autophagy-the process in which cells digest some of their contents-according to a study in the September 20 issue of the Journal of Cell Biology

21 Sep 2010

Parkinson's Disease News and Research

Latest Parkinson's Disease News and Research

COE on Brain Aging at NYU Langone establishes Lewy Body Disease Center

NINDS establishes new sites as part of Morris K. Udall Centers of Excellence in Parkinson's Disease Research

Synosia's SYN-118 HPPD inhibitor beneficial for Parkinson's patients: Study

Brain cells outside damaged area in stroke patients take on new roles

XenoPort to present XP21279 clinical trial data at World Parkinson Congress meeting

Study indicates majority of children suffering from chronic headache may outgrow the condition

Higher education levels increases need for symptomatic control of Parkinson's disease

Michael J. Fox Foundation launches PPMI clinical study to identify Parkinson's disease biomarkers

People with Parkinson's disease have high levels of beta-HCH pesticide

Alzheimer's treatments may prove effective if started in middle-aged people: Study

Individuals with growing amount of white matter hyperintensities are more likely to develop dementia

FDA designates AMT-080 gene therapy for Duchenne muscular dystrophy

Gait disruption increases risk of falls in Parkinson's patients: Study

New study signals hope for treatment of rare neurodegenerative disease

ARRA's legacies may solve challenges related to health, energy and environment

Researchers explain how nerve cells transmit electrical signals

Deep brain stimulation improves OCD symptoms, promotes smoking cessation and weight loss

ASM awards UTHealth student 3-year, $33,000 fellowship for study of molecular details of protein folding in cells

Voice disorders are not benign nuisances that go away

Alpha-synuclein protein in Parkinson's disease inhibits autophagy: Research

eBook: Advancing neurodegenerative research with iPSC-derived microglia models eBook

Fluidics in Modern Healthcare & Medical Device Innovation

Scaling 3D biology: Automation, imaging, and the future of high-throughput research

How does norepinephrine influence anxiety-related behaviours?

Parkinson's Disease News and Research

Latest Parkinson's Disease News and Research

eBook: Advancing neurodegenerative research with iPSC-derived microglia models eBook

Fluidics in Modern Healthcare & Medical Device Innovation

Scaling 3D biology: Automation, imaging, and the future of high-throughput research

How does norepinephrine influence anxiety-related behaviours?

Newsletters you may be interested in